Skip to main content

Table 2 Participant characteristics at baseline

From: Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation

Characteristic Snus group (n = 158) Placebo group (n = 161)
Age, mean (SD), years 43.3 (9.9) 44.0 (10.3)
Female (%) 99 (62.7) 97 (60.2)
Weight, mean (SD), kg 76.4 (16.5) 75.8 (16.4)
Height, mean (SD), cm 170.6 (8.8) 171.9 (10.0)
BMI (kg/m2), mean (SD) 26.1 (4.7) 25.5 (4.1)
Age at smoking initiation, mean (SD), years 19.2 (5.3) 18.8 (4.0)
Average no. of smoked cigarettes per day during last year, mean (SD) 27.6 (10.5) 25.7 (9.0)
No. of previous quit attempts, mean (SD) 0.7 (1.4) 0.6 (1.3)
Previous NRT exposure (%) 1 (0.6) 2 (1.2)
Previous exposure to other pharmaceutical smoking cessation products (%) 1 (0.6) 3 (1.9)
Intention to participate was to quit smoking (%) 132 (83.5) 127 (78.9)
FTND score, mean 6.2 6.1
  1. SD: standard deviation, NRT: nicotine replacement therapy, FTND: Fagerström test for nicotine dependence